{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:02:10Z","timestamp":1790560930633,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbmt.2020.05.006","type":"journal-article","created":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:02:17Z","timestamp":1589680937000},"page":"1729-1737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"26","author":[{"given":"Anne","family":"Conrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elodie","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Labussi\u00e8re-Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Barraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ducastelle-Lepr\u00eatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Virginie","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Balsat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Boccard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Chidiac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Roure-Sobas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Valour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Ader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2020.05.006_bib0001","unstructured":"Apperley J, Carreras E, Gluckman E, Masszi T. Revised edition of the European Bone Marrow Transplantation (EBMT)-European Society of Haematology (ESH) Handbook on Haematopoietic Stem Cell Transplantation. Available at:https:\/\/ebmtonline.forumservice.net\/. Accessed March 4, 2019."},{"key":"10.1016\/j.bbmt.2020.05.006_bib0002","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0003","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/bmt.2012.5","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"47","author":"Majhail","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0004","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0005","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2012.46.6193","article-title":"Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors","volume":"31","author":"Hahn","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0006","unstructured":"D'Souza A, Fretham C.Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides. 2018. Available at:https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages\/index.aspx#CiteSummarySlides. Accessed July 14, 2019."},{"key":"10.1016\/j.bbmt.2020.05.006_bib0007","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/blood.V70.3.779.779","article-title":"Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation","volume":"70","author":"Aucouturier","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0008","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.bmt.1705964","article-title":"Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance","volume":"41","author":"Kumar","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0009","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/bmt.2015.160","article-title":"Functional hyposplenism after hematopoietic stem cell transplantation","volume":"50","author":"Rozmus","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0010","first-page":"225","article-title":"Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients","volume":"14","author":"Li Volti","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0011","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1699-0463.1996.tb00731.x","article-title":"Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation","volume":"104","author":"Parkkali","year":"1996","journal-title":"APMIS"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0012","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bmt.1700768","article-title":"A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT","volume":"19","author":"Parkkali","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0013","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V84.2.657.657","article-title":"Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation","volume":"84","author":"Ljungman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0014","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2007.05.009","article-title":"Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer","volume":"13","author":"Kaloyannidis","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1704870","article-title":"Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT","volume":"35","author":"Ljungman","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0016","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2011.02.018","article-title":"Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD","volume":"29","author":"Hilgendorf","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0017","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0018","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0019","series-title":"Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques. Recommandations actualis\u00e9es","year":"2014"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0020","unstructured":"Australian Government, Department of Health. Recommendations for revaccination after haematopoietic stem cell transplant in children and adults. 2018. Available at:https:\/\/immunisationhandbook.health.gov.au\/resources\/handbook-tables\/table-recommendations-for-revaccination-after-haematopoietic-stem-cell. Accessed July 14, 2019."},{"key":"10.1016\/j.bbmt.2020.05.006_bib0021","unstructured":"Government of Canada. Immunization of immunocompromised persons: Canadian Immunization Guide. 2007. Available at:https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-3-vaccination-specific-populations\/page-8-immunization-immunocompromised-persons.html#t3. Accessed November 6, 2019."},{"key":"10.1016\/j.bbmt.2020.05.006_bib0022","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0023","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0024","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"Lee","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0027","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0028","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.2011.08913.x","article-title":"Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation","volume":"156","author":"Inaba","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0029","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.bbmt.2015.08.010","article-title":"Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies","volume":"21","author":"Shah","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1086\/511636","article-title":"Revaccination of children after completion of standard chemotherapy for acute leukemia","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0031","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1111\/j.1651-2227.2012.02710.x","article-title":"Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation","volume":"101","author":"Olkinuora","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0032","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1182\/blood-2006-04-006981","article-title":"Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants","volume":"108","author":"Jaffe","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0033","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0163-4453(86)92668-X","article-title":"Overview of clinical studies with hepatitis B vaccine made by recombinant DNA","volume":"13","author":"Zajac","year":"1986","journal-title":"J Infect"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0034","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/jama.2011.351","article-title":"Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial","volume":"305","author":"Launay","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0035","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/344271","article-title":"Effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis","volume":"35","author":"Fisman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0036","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"21","author":"Arai","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0037","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0038","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0190-9622(99)70257-4","article-title":"Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens","volume":"41","author":"Suchin","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0039","series-title":"Vaccination & Immunoprophylaxis: General Recommendations. CDC Yellow Book 2020: Health Information for International Travel","year":"2017"},{"key":"10.1016\/j.bbmt.2020.05.006_bib0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejps.2009.02.014","article-title":"Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency","volume":"37","author":"Wasserman","year":"2009","journal-title":"Eur J Pharm Sci"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120302949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120302949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:11:35Z","timestamp":1761059495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879120302949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1083879120302949"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.05.006","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}